Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 29 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

23%

3 of 13 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (4)
P 1 (1)
P 2 (2)
P 4 (2)

Trial Status

Completed13
Recruiting11
Not Yet Recruiting3
Active Not Recruiting1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (29)

Showing 20 of 20 trials
NCT07556224RecruitingPrimary

Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study

NCT07536529Recruiting

Oxidative Stress in Autoimmune Rheumatic Diseases

NCT06844643Recruiting

The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study

NCT07509775RecruitingPrimary

Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System

NCT07262294Not ApplicableRecruitingPrimary

Deep Breathing Combined With Core Stability Exercises in the Treatment of Patients With Ankylosing Spondylitis

NCT07441239CompletedPrimary

Patient-Reported Sleep vs Objective Sleep and Physical Activity Measures in Ankylosing Spondylitis: A Pre-Post Study

NCT04541810Completed

A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

NCT05303285Phase 4RecruitingPrimary

A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis

NCT04806620Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

NCT07327073Not ApplicableNot Yet RecruitingPrimary

The Effect of Exercise on Serum Irisin Levels and Clinical Parameters in Patients With Axial Spondyloarthritis.

NCT07128264Not ApplicableNot Yet RecruitingPrimary

The Effect of Laughter Yoga on Patients With Ankylosing Spondylitis

NCT06739369RecruitingPrimary

The Relationship Between Arterial Stiffness and Pulmonary and Extrapulmonary Features in Ankylosing Spondylitis

NCT06707194Phase 4Recruiting

Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis

NCT06988813Recruiting

Bidirectional Cohort Study of Nanfang Spondyloarthritis

NCT06888973Phase 1Enrolling By Invitation

Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases

NCT06873074CompletedPrimary

A Retrospective Cohort Study About Surgical Efficacy for Lower Cervical Fractures in Ankylosing Spondylitis

NCT06766552Not Yet RecruitingPrimary

A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.

NCT06688929Completed

Psychosocial and Functional Factors in AxSpA

NCT06650228RecruitingPrimary

Cardiovascular Disease Risk Factors and Healthy Lifestyle Behaviours in Patients with Ankylosing Spondylitis

NCT02389075Active Not Recruiting

The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis

Scroll to load more

Research Network

Activity Timeline